Apollo Hospitals Enterprise Ltd Share Price

Healthcare

NSE: APOLLOHOSP Large Cap ISIN: INE437A01024

As on 20 March 2025 at 19:24 IST

₹6,474.35

+ 46.80

(0.73%)

Sell Buy

Q3 Results:

Apollo Hospitals Enterprise Ltd Q3 Results: Total income in Q3 FY25 rose 15.2% to ₹49.720 billion, from ₹43.186 billion in the same period last year. Net profit increased 77.3% to ₹2.584 billion on a yearly basis, compared to ₹1.456 billion in Q3 FY24.

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd was established in 1983. It is a leading integrated healthcare provider in India. Apollo Hospitals is headquartered in Chennai, Tamil Nadu. The company has become one of the largest and most significant players in India’s private healthcare sector. Apollo Hospitals has years of experience. It operates a vast network of hospitals and pharmacies. It also operates primary care and diagnostic clinics along with telemedicine units. Their services range from routine wellness to preventive healthcare. The company even caters to innovative life-saving treatments along with advanced diagnostic services. +

Over 1 Month

0.08%

Over 6 Months

-8.57%

Over 1 Year

5.14%

Over 3 Years

34.82%

Apollo Hospitals Enterprise Ltd Summary

Close ₹6,474.35

Open ₹6,465

High ₹6,484.65

Low ₹6,363.75

Volume 4,57,285

Net Turnover (in Cr) ₹294.21

52Wk High ₹7,545.35

52Wk Low ₹5,693.20

52Wk High / Low

5,693.20

7,545.35

Apollo Hospitals Enterprise Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹92,418.31

EPS (TTM) 83.58

Book Value (BV) 569.63

Div. Yield 0.25 %

P/E (TTM) 76.88

Price/Book Value 11.28

Delivery % 68.67 %

Face Value 5

Key Ratios

PE Ratio 90.39

PB Ratio 11.85

EV to Sales 12.95

PEG Ratio -13.19

ROA 9.24

ROE 13.81

Debt-Equity 0.39

Net Profit Margin 13.89

Operating Profit Margin 27.19

Apollo Hospitals Enterprise Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	19,165.50	16,702.80	14,740.80	10,605	11,273.80
Total Expenses	17,804.90	15,559.10	13,456.80	10,444.90	10,812.10
Profit Before Tax	1,362.50	1,143.70	1,578.10	220.70	660
Profit After Tax	917	887.50	1,101.10	136	434.80
Operating Profit after Depreciation	1,810	1,524.50	1,662.60	609.30	994.50

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	9,688.60	8,523.90	8,292.40	6,795.30	7,452.70
Total Non Current Assets	11,473.40	10,090.80	9,208.70	7,775.40	8,691.50
Total Current Assets	5,279.70	4,337	4,060.60	3,641.30	2,646.90
TOTAL ASSETS	16,753.10	14,427.80	13,269.30	11,416.70	11,338.40
Total Shareholder's Fund	6,935.40	6,197.40	5,623.30	4,602.50	3,339.10

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1,920.20	1,376.90	1,696	1,264.60	1,292.90
Net Cash used in Investing Activities	-1,537.10	-856.80	-746.60	-880	-288.80
Net Cash used in Financing Activities	-311	-633.20	-791.60	-340.10	-909.60

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	7,453.70	6,676.30	6,145.30	4,670.90	9,805.30
Total Expenses	6,125.10	5,448.80	5,286.30	4,702.20	9,287.40
Profit Before Tax	1,328.60	1,227.50	852.30	-40.40	682.30
Profit After Tax	1,010.50	1,084.80	572.50	-26.40	470.20
Operating Profit after Depreciation	1,578.40	1,466.30	1,103	308.70	943.80

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	6,058.80	5,085.40	5,122.30	5,060.30	6,082.20
Total Non Current Assets	8,730.10	7,629.70	6,953	6,691.50	7,829.20
Total Current Assets	3,675.10	3,150.70	3,455.20	3,037.70	2,315
TOTAL ASSETS	12,405.20	10,780.40	10,408.20	9,729.20	10,144.20
Total Shareholder's Fund	7,710.90	6,924.80	6,110.70	5,201.50	3,988.40

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1,191.40	1,224.50	1,200.90	915.50	1,096.10
Net Cash used in Investing Activities	-835.30	-588.50	-504	-781.10	-263.90
Net Cash used in Financing Activities	-297	-778.60	-576.60	-175.60	-770.70

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	5,526.90	5,589.30	5,085.60	4,943.90	4,850.60
Total Expenses	4,765.40	4,773.80	4,410.50	4,303.40	4,236.90
Profit Before Tax	536.20	557.40	430	368.20	363.30
Profit After Tax	379.40	395.70	315.50	258.40	254.40
Operating Profit after Depreciation	830.60	859.40	723.80	677.20	642.90

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	2,054.80	2,135.40	1,936.60	1,894.60	1,824.30
Total Expenses	1,543	1,595.10	1,465.80	1,444.20	1,374
Profit Before Tax	449.30	487.50	331.70	312.40	344
Profit After Tax	341.60	369.60	251.70	238.80	262.80
Operating Profit after Depreciation	619.70	661.20	498.10	496.40	501.80

Apollo Hospitals Enterprise Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 6,291.47

S2 6,155.38

S3 6,083.67

Pivot 6,363.18

R1 6,499.27

R2 6,570.98

R3 6,707.07

Moving Average

20 SMA 6,233.83

50 SMA 6,546.48

100 SMA 6,838.19

200 SMA 6,737.86

Apollo Hospitals Enterprise Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Apollo Hospitals Enterprise Ltd

₹9/Share

Announcement Date 14 Feb 2025

Record Date 15 Feb 2025

Div Yield 180%

Apollo Hospitals Enterprise Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,088.15	₹1,05,783.64
Fortis Healthcare Ltd	₹610.50	₹46,090.19
Narayana Hrudayalaya Ltd	₹1,645.40	₹33,625.53
Global Health Ltd	₹1,227.30	₹32,963.73
Syngene International Ltd	₹706.05	₹28,421.12

Apollo Hospitals Enterprise Ltd Top Mutal Funds Invested

Fund Name	AUM
SBI Nifty 50 ETF	0.62%
HDFC Flexi Cap Fund	1.53%
Invesco India Contra Fund	2.70%
Mirae Asset Large Cap Fund	1.19%
Mirae Asset Large & Midcap Fund	1.24%

Apollo Hospitals Enterprise Ltd News

Board of Apollo Hospitals Enterprise recommends interim dividend

Of Rs 9 per share

11 Feb 2025, 09:23 am

Apollo Hospitals Enterprise announces board meeting date

On 10 February 2025

20 Jan 2025, 12:59 pm

Apollo Hospitals hits record high after Q2 PAT climbs 63% YoY to Rs 379 cr

Apollo Hospitals Enterprise jumped 6.92% to Rs 7,452 after the company reported 62.64% surge in consolidated net profit to Rs 378.8 crore in Q2 FY25 as against Rs 232.9 crore posted in Q2 FY24.

07 Nov 2024, 11:50 am

Stock Alert: Apollo Hospital Enterprise, Tata Steel, Power Grid Corporation of India, Sonata Software,

07 Nov 2024, 08:30 am

Apollo Hospitals Q2 PAT climbs 63% YoY to Rs 379 cr

Apollo Hospitals Enterprise reported 62.64% surge in consolidated net profit to Rs 378.8 crore in Q2 FY25 as against Rs 232.9 crore posted in Q2 FY24.

06 Nov 2024, 05:49 pm

Apollo Hospitals Enterprise Ltd Stock Analysis

Annual revenue for Apollo Hospitals Enterprise Ltd increased by 11.64% to ₹7,453.70 crore in FY 2024 from ₹6,676.30 crore in FY 2023.
Annual Net Profit for Apollo Hospitals Enterprise Ltd decreased by 6.85% to ₹1,010.50 crore in FY 2024 from ₹1,084.80 crore in FY 2023.
Promoter Shareholding in Apollo Hospitals Enterprise Ltd remains unchanged by 0.00% in the most recent quarter, from 29.33% in September 2024 to 29.33% in December 2024.
Apollo Hospitals Enterprise Ltd delivered a 1-year return of 5.14% compared to the Nifty 50, which provided a return of 5% as of the last trading session.
Apollo Hospitals Enterprise Ltd share price moved up by 0.73% from its previous close of INR ₹6,427.55. The latest Apollo Hospitals Enterprise Ltd share price is INR ₹6,474.35.
Apollo Hospitals Enterprise Ltd share price today has been at a low of 6,363.75 and a high of 6,484.65. Over the past 52 weeks, the Apollo Hospitals Enterprise Ltd share price has seen a low of 5,693.20 and a high of 7,545.35.

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd. was established in 1983. It is a leading integrated healthcare provider in India. The company has many years of experience and operates a vast network of hospitals and pharmacies. It also operates primary care, diagnostic clinics, and telemedicine units. Their services range from routine wellness to preventive healthcare. The company also caters to innovative life-saving treatments and advanced diagnostic services.

Apollo Hospitals is headquartered in Chennai, Tamil Nadu. The company has become one of the largest and most significant players in India’s private healthcare sector. The company has an extensive network, including multispecialty and super-speciality hospitals. It also includes a wide array of pharmacies and advanced diagnostic centers. They also provide telemedicine facilities for remote consultations. Additionally, they offer health insurance services, ensuring complete healthcare solutions for their patients.

The promoters of Apollo Hospitals Enterprise Ltd. are key figures in the healthcare industry. The leadership team has many people who hold various executive positions within the company. They hold a 29.33% stake in the company. Their combined expertise and vision have driven the company’s growth and success.
Here are the key managing promoters:

Dr. Prathap C. Reddy
Ms. Preetha Reddy
Ms. Suneeta Reddy
Ms. Sangita Reddy
Mr. Som Mittal

Apollo Hospitals’ registered office is at 19 Bishop Gardens, Raja Annamalai Puram, Chennai. The company’s registrars are Integrated Registry Management Services Private Ltd. It has a strong management team and a commitment to excellence. Apollo Hospitals continues to lead the way in providing premium healthcare services across India.

Influence of the Company

Dr. Prathap C. Reddy founded Apollo Hospitals Enterprise Ltd.. It has significantly influenced the healthcare landscape in India and beyond. Apollo Hospitals has set benchmarks in quality healthcare. It is a pioneer in the private healthcare sector. This is reflected in its extensive web presence and influence.

Comprehensive Healthcare Services
Apollo Hospitals offers various healthcare services, including multispecialty and super-specialty hospitals. Their services also include pharmacies, diagnostic centers, and telemedicine units. Their services encompass routine wellness and preventive healthcare. They also provide innovative life-saving treatments and advanced diagnostic services. This thorough approach ensures that Apollo Hospitals caters to broad healthcare needs. This feature makes it a trusted name in the industry.

Digital Transformation and Telemedicine
One of the big influences of Apollo Hospitals Enterprise Ltd. is its early adoption of digital transformation and telemedicine. The company has leveraged technology to provide remote consultations. It is making healthcare accessible to patients in remote and underserved areas. Their telemedicine services have been particularly impactful during the COVID-19 pandemic. It has ensured continuity of care while minimizing the risk of infection. This digital shift has been covered and discussed on various online platforms. It highlights Apollo’s role in modernizing healthcare delivery.

Health Information and Awareness
Apollo Hospitals Enterprise Ltd. has also been a key player in distributing health information. They are also raising awareness about various medical conditions. This has been made possible through their website, blogs, and social media channels. They provide valuable information on preventive healthcare, treatment options, and wellness tips. This educational content helps patients make informed decisions about their health. The company has been successful in fostering a proactive approach to healthcare. The company’s commitment to health education is evident in its extensive online resources. These resources are referenced by other health websites and forums.

Corporate Social Responsibility (CSR)
Apollo Hospitals’ influence extends beyond healthcare services to its CSR initiatives. The company is involved in various community health programs. It is also involved in disaster relief efforts and health camps. These initiatives are covered on the web. They showcase Apollo’s commitment to giving back to society and improving public health. Their CSR activities enhance the company’s reputation. It inspires other organizations to undertake similar initiatives.

Market Leadership and Financial Performance
Apollo Hospitals’ market leadership and financial performance are frequently discussed topics. They are covered on financial news websites and investment forums. The company’s stock performance, market share, and growth strategies are analyzed regularly by financial experts and investors. These contribute to its strong online presence. Apollo Hospitals’ uniform performance and strategic growth have made it a liked choice for investors. This further amplifies its influence on healthcare investments.

Patient Testimonials and Reviews
Patient feedback and reviews are crucial in shaping Apollo Hospitals’ online reputation. Positive patient experiences and success stories are shared across various platforms. It will be on the company’s website, social media, and healthcare review sites. These testimonials build trust among potential patients. It also highlights the quality of care provided by Apollo Hospitals Enterprise Ltd. The company is responsive to patient feedback and committed to continuous improvement. These are key factors in maintaining a positive online presence.

Apollo Hospitals Enterprise Ltd.’s influence is multifaceted. It covers healthcare services, digital transformation, health education, CSR initiatives, and patient experiences. The company’s obligation to goodness has made it a prominent name in the healthcare industry. Apollo Hospitals continues to develop and change. It will further solidify its position as a leader in the healthcare sector.